{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:17:49Z","timestamp":1776982669955,"version":"3.51.4"},"reference-count":30,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,1,31]]},"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p><jats:italic>Trichomonas vaginalis<\/jats:italic>is the most common curable sexually transmitted infection worldwide.<jats:italic>T vaginalis<\/jats:italic>infections in women can range from asymptomatic to acute inflammatory vaginitis. In men, this infection is typically asymptomatic but is increasingly being recognised as a cause of non-gonococcal urethritis. Diagnosis of<jats:italic>T vaginalis<\/jats:italic>has traditionally been made by direct microscopic examination of a wet mount of vaginal fluid or through the use of culture. The recent commercial availability of nucleic acid amplification tests for the detection of<jats:italic>T vaginalis<\/jats:italic>has seen these replace culture as the gold standard for diagnosis. Nitroimidazoles (ie, metronidazole and tinidazole) are the mainstay of therapy. In the case of treatment failure due to drug resistance or in the case of a severe nitroimidazole allergy, alternative intravaginal therapies exist, although their effectiveness has not been evaluated systematically. Novel systemic agents other than nitroimidazoles for the treatment of<jats:italic>T vaginalis<\/jats:italic>are needed, and efforts to promote and support antimicrobial drug development in this setting are necessary.<\/jats:p>","DOI":"10.1136\/sextrans-2012-050893","type":"journal-article","created":{"date-parts":[[2013,3,31]],"date-time":"2013-03-31T01:16:20Z","timestamp":1364692580000},"page":"423-425","source":"Crossref","is-referenced-by-count":46,"title":["The clinical spectrum of<i>Trichomonas vaginalis<\/i>infection and challenges to management"],"prefix":"10.1136","volume":"89","author":[{"given":"Christina A","family":"Muzny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane R","family":"Schwebke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,3,30]]},"reference":[{"key":"2024051410024867000_89.6.423.1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.4.794-803.2004"},{"key":"2024051410024867000_89.6.423.2","doi-asserted-by":"publisher","DOI":"10.1086\/522532"},{"key":"2024051410024867000_89.6.423.3","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199707000-00009"},{"key":"2024051410024867000_89.6.423.4","doi-asserted-by":"publisher","DOI":"10.1086\/511278"},{"key":"2024051410024867000_89.6.423.5","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00748-12"},{"key":"2024051410024867000_89.6.423.6","first-page":"745","article-title":"Vaginitis","volume":"36","author":"Sparks","year":"1991","journal-title":"J Reprod Med"},{"key":"2024051410024867000_89.6.423.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-11-199306010-00003"},{"key":"2024051410024867000_89.6.423.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03720080057028"},{"key":"2024051410024867000_89.6.423.9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01291-11"},{"key":"2024051410024867000_89.6.423.10","doi-asserted-by":"crossref","unstructured":"Schwebke J Lawing L . Improved detection of Trichomonas vaginalis in males using DNA amplification. J Clin Microbiol 2002:3681\u20133.","DOI":"10.1128\/JCM.40.10.3681-3683.2002"},{"key":"2024051410024867000_89.6.423.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003329"},{"key":"2024051410024867000_89.6.423.12","first-page":"207","article-title":"Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992\u20131993","volume":"71","author":"Leroy","year":"1995","journal-title":"Genitourin Med"},{"key":"2024051410024867000_89.6.423.13","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199301000-00015"},{"key":"2024051410024867000_89.6.423.14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(05)78181-2","article-title":"Trichomonas vaginalis and amplification of HIV-1 transmission","volume":"351","author":"Sorvillo","year":"1998","journal-title":"Lancet"},{"key":"2024051410024867000_89.6.423.15","unstructured":"CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59."},{"key":"2024051410024867000_89.6.423.16","first-page":"348","article-title":"Prenatal use of metronidazole and birth defects: no association","volume":"82","author":"Piper","year":"1993","journal-title":"Obstet Gynecol"},{"key":"2024051410024867000_89.6.423.17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90567-7"},{"key":"2024051410024867000_89.6.423.18","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181eda955"},{"key":"2024051410024867000_89.6.423.19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/OLQ.0b013e3181dd1691","article-title":"A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women","volume":"37","author":"Schwebke","year":"2010","journal-title":"Sex Transm Dis"},{"key":"2024051410024867000_89.6.423.20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00814-06"},{"key":"2024051410024867000_89.6.423.21","doi-asserted-by":"publisher","DOI":"10.3201\/eid1806.111590"},{"key":"2024051410024867000_89.6.423.22","doi-asserted-by":"publisher","DOI":"10.1086\/323034"},{"key":"2024051410024867000_89.6.423.23","doi-asserted-by":"publisher","DOI":"10.1086\/513951"},{"key":"2024051410024867000_89.6.423.24","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31822037e4"},{"key":"2024051410024867000_89.6.423.25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1701-2163(16)32714-1","article-title":"Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification","volume":"30","author":"Aggarwal","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"2024051410024867000_89.6.423.26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ajog.2007.10.795","article-title":"Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity","volume":"198","author":"Helms","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2024051410024867000_89.6.423.27","doi-asserted-by":"publisher","DOI":"10.1071\/SH11114"},{"key":"2024051410024867000_89.6.423.28","doi-asserted-by":"publisher","DOI":"10.1071\/SH09064"},{"key":"2024051410024867000_89.6.423.29","first-page":"954","article-title":"Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9","volume":"78","author":"Livengood","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2024051410024867000_89.6.423.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1990.tb03255.x"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2012-050893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:03:25Z","timestamp":1715706205000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2012-050893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,30]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,8,16]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1136\/sextrans-2012-050893"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2012-050893","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,30]]}}}